Study on the Safety of TAK-755, Rituximab, and Glucocorticoids for Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP)
- Substances:Apadamtase AlfaRituximab
Spain- Participants:18–64 years · 65+ years
- Substances:Apadamtase Alfa
Rare diseases
Investigational molecules
Locations
SpainStudy Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib
SpainStudy of Elranatamab for Patients with Multiple Myeloma Resistant to Proteasome Inhibitors, Immunomodulatory Drugs, and Anti-CD38 Antibodies
SpainStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
SpainStudy on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment
SpainStudy Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults
SpainStudy Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma
SpainStudy of Tirzepatide for Reducing Obesity and Related Health Issues in Adolescents
SpainStudy on Basimglurant for Children, Adolescents, and Young Adults with Tuberous Sclerosis Complex-Related Seizures
SpainStudy of AloCelyvir for Patients with Metastatic Uveal Melanoma
SpainStudy on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration
SpainStudy on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.